Source briefing
Human medicines European public assessment report (EPAR): Tafamidis Accord, tafamidis, Date of authorisation: 18/09/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Tafamidis Accord, tafamidis, Date of authorisation: 18/09/2026, Status: Authorised
Read →
Source briefing
From wrist to research: Harnessing smartwatch data for equitable cardiovascular research
by Manpreet Kaur, on behalf of the PLOS Medicine Staff Editors Cardiovascular disease is a leading cause of death, and progress in reducing mortality has stalled, calling for more research. An opportunity lies in harnessing cardiovascular data from…
Read →Source briefing
Harvard launches $150 million research initiative
University plans range of awards in basic and applied science, seeking to meet ‘moment of remarkable opportunity’
Read →Source briefing
Reform of the EU pharmaceutical legislation
Reform of the EU pharmaceutical legislation
Read →Source briefing
Human medicines European public assessment report (EPAR): Pemetrexed Baxter, pemetrexed, Date of authorisation: 09/12/2022, Status: Withdrawn
Human medicines European public assessment report (EPAR): Pemetrexed Baxter, pemetrexed, Date of authorisation: 09/12/2022, Status: Withdrawn
Read →Source briefing
Evidence brief: From evidence to practice – successful models for improved testing, linkage to and retention in care for migrant populations, related to HIV, TB, viral hepatitis and STIs in the EU/EEA
Migrant populations often face unique and intersecting barriers that can delay diagnosis and interrupt continuity of care, including language differences, cultural and health literacy gaps, uncertain legal status, stigma, and limited familiarity with healthcare systems.
Read →Source briefing
Odette Harris on Concussion, Brain Injury, and Why Every Sport Carries Risk
Odette Harris, MD, MPH, Professor of Neurosurgery and the Paralyzed Veterans of America Professor of Spinal Cord Medicine at Stanford, joins The Future of Medicine for a conversation about concussion, traumatic brain injury, and what it takes to…
Read →Source briefing
How Harvard scientists built genomics outpost on Gloucester harbor
It started with idea to help beleaguered fishermen. Now marine science lab promotes healthy fisheries, trains local workforce, seeks clues to longevity
Read →Source briefing
Communicable disease threats report, 19-25 September, week 39
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 September, and includes updates on respiratory virus epidemiology in the EU/EEA Ebola, ECDC expert deployment, West Nile Virus, Crimean-Congo haemorrhagic fever, dengue, chikungunya, and…
Read →Source briefing
Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, Date of authorisation: 11/02/2021, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, Date of authorisation: 11/02/2021, Revision: 22, Status: Authorised
Read →